l e t t e r s The TGF-β family comprises three cytokines that regulate multiple aspects of cellular behavior, including proliferation, differentiation, migration and specification of synthetic repertoire 1 . Postnatally, TGF-β activity is most closely linked to wound healing, productive modulation of the immune system and multiple pathological processes, including cancer progression and tissue fibrosis 2 . Fibrillin-1, encoded by FBN1, the gene altered in MFS 3 , binds to the latent TGF-β complex and regulates the release of active cytokine into the extracellular environment 4,5 . LDS is a syndromic presentation of aortic aneurysm that is most often caused by mutations in the genes that encode the subunits of the TGF-β receptor, TGFBR1 and TGFBR2 (refs. 6,7). Mutations in SMAD3, which encodes an intracellular mediator of TGF-β signaling, have also been described in individuals with phenotypic manifestations of LDS 8 . Three TGF-β ligand isoforms exist in humans (TGF-β1, TGF-β2 and TGF-β3, encoded by the TGFB1, TGFB2 and TGFB3 genes, respectively), but their relative contributions to aortic aneurysm in the context of connective tissue disorders has not been explored.
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The precise role of TGF-β signaling in aneurysm progression remains controversial. On the one hand, analyses of the aortic wall in affected persons and mouse models have consistently shown a signature of increased TGF-β signaling in MFS, LDS, cutis laxa with aneurysm, bicuspid aortic valve with aneurysm and isolated familial thoracic aortic aneurysm caused by mutations affecting smooth muscle cell contractile proteins 6, [9] [10] [11] . This signature includes increased phosphorylation and nuclear translocation of the receptor-activated SMAD proteins (SMAD2 and SMAD3), increased expression of TGF-β-responsive gene products (for example, collagen, connective tissue growth factor (CTGF) and plasminogen activator inhibitor-1) and/or increased activation of noncanonical TGF-β signaling cascades (prominently including ERK1 and ERK2 (ERK1/2)) 12 . In mouse models of MFS, antagonism of TGF-β signaling using either TGF-β-neutralizing antibodies or angiotensin receptor blockers attenuates multisystem disease manifestations, including aortic aneurysm 11, 13, 14 . On the other hand, intuitive consideration of the primary consequences Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm l e t t e r s of many disease-associated mutations suggests the potential for loss of TGF-β signaling 7 . For example, whereas the fibrillins can contribute to negative regulation of TGF-β signaling by sequestering the TGF-β latent complex, they can also positively regulate signaling by concentrating cytokine at sites of intended function 15 . Most mutations in LDS involve substitution of conserved residues in the kinase domains of the TGF-β receptor subunits, and recombinant expression of receptors harboring LDS mutations in cells naïve for the corresponding receptor subunit fails to support canonical (SMAD-dependent) TGF-β signaling 16 . At least some of the SMAD3 mutations that cause LDS are expected to confer functional haploinsufficiency and thus reduce signaling potential 8 . Furthermore, lineage-specific abrogation of TGF-β signaling can impair aortic wall homeostasis 17, 18 . It has been our hypothesis that this apparent paradox can be reconciled if compensatory autocrine or paracrine events in response to a relative loss of TGF-β signaling potential lead to functional overshoot 19 . Here, we describe the identification and mechanistic characterization of a new gene underlying a syndromic aneurysm presentation within the LDS spectrum that lends validity to this pathogenic model.
We identified eight families with an autosomal dominant aortic aneurysm phenotype with variable clinical expression. Features shared with MFS and LDS included aortic aneurysm, pectus deformity, arachnodactyly, scoliosis and skin striae. Features shared with LDS but not with MFS included hypertelorism, bifid uvula, bicuspid aortic valve, arterial tortuosity, club feet and thin skin with easy bruising (Fig. 1 (Figs. 1 and 2a) . The deletion in one proband was 6.5 Mb in length (215,588,712-222,145,072 Mb; GRCh37/hg19) and encompassed 20 genes, whereas the other deletion was only 3.5 Mb in length (216,672,181-220,202,575 Mb). Both deletions included the TGFB2 gene, which encodes TGF-β2, making it an obvious candidate gene for this aneurysm phenotype with MFS-and LDS-like features. We subsequently sequenced all exons and intron-exon boundaries of the TGFB2 gene in a cohort of 86 individuals with aneurysm (34% familial) who did not have FBN1, TGFBR1 and TGFBR2 mutations. We identified a total of six additional heterozygous mutations in TGFB2, including one nonsense mutation, three missense mutations and two intragenic deletions, one in frame and one causing a frameshift ( Fig. 2b and Supplementary  Fig. 1 ). The three missense mutations, encoding p.Arg327Trp, p.Arg330Cys and p.Pro366His, resulted in the substitution of evolutionarily conserved residues (Fig. 2b) and were categorized as probably damaging by Polyphen 20 , as deleterious by SIFT 21 and as disease causing by MutationTaster 22 . In addition, these mutations were not observed in data from the 1000 Genomes Project 23 and were not present in over 10,000 exomes in the National Heart, Lung, and Blood Institute (NHLBI) Exome Variant Server. All participating affected individuals tested positive for their family-specific TGFB2 mutation (Fig. 2c) . Because we found two whole-gene deletions in addition to two nonsense mutations predicted to lead to nonsense-mediated mRNA decay (encoding p.Tyr99* and p.Tyr369Cysfs*26), we propose haploinsufficiency as the relevant mechanism.
In addition to aneurysm, individuals with LDS show arterial tortuosity with prominent involvement of the vertebral and carotid arteries 6, 16 . Individuals with TGFB2 mutations can have similar arterial tortuosity ( npg l e t t e r s elastic fiber fragmentation and higher collagen and proteoglycan deposition (Fig. 3b,c and Supplementary Fig. 2 ), histopathological findings that are reminiscent of both MFS and LDS 24 . Immunohistochemistry (IHC) analysis of aortic tissue from subjects 7:III-1 and 5:II-2 showed higher TGF-β signaling, as evidenced by greater nuclear accumulation of phosphorylated SMAD2 and SMAD3 proteins and higher expression of TGF-β-responsive gene products, including collagen and CTGF (Fig. 3c,d and Supplementary Fig. 2 ). Whereas total TGF-β2 expression in IHC analyses was similar in affected individuals and in controls, expression of TGF-β1 ligand was higher in affected individuals (Fig. 3d) . 
l e t t e r s
We next examined the effect of Tgfb2 haploinsufficiency in genetargeted mice. Whereas homozygous knockout (Tgfb2 −/− ) mice are known to show late embryonic lethality secondary to congenital heart disease 25 , the phenotype of mice targeted in one allele (Tgfb2 +/− ) had not been reported in detail. Humans with LDS develop aortic aneurysm with a typical anatomical distribution characterized by dilation of the aortic root at the level of the sinuses of Valsalva 6 . The pattern is similar in humans with MFS 26 and in mouse models of MFS harboring a heterozygous fibrillin-1 mutation (Fbn1 C1039G/+ ) (ref. 27 ). By 8 months of age, Tgfb2 +/− mice showed dilation of the aortic annulus and root, but the dimensions of the more distal ascending aorta were normal (Fig. 4a,b) . These findings show that loss of function of a single allele of Tgfb2 is sufficient to cause aortic root aneurysm. To interrogate TGF-β signaling in Tgfb2 +/− mice, we performed protein blot analysis of lysates derived from proximal ascending aortic segments. Similar to the signaling perturbations seen in Fbn1 C1039G/+ mice 12, 28 , aortas from Tgfb2 +/− mice showed increased phosphorylation of Smad2, Smad3 and Erk1/2 compared to wild-type mice ( Fig. 4c and Supplementary Fig. 3) .
We next assessed whether there was a genetic interaction between targeted Tgfb2-null and Fbn1 C1039G alleles. The latter is associated with high TGF-β signaling during periods of rapid aneurysm progression 11, 12, 29 . Tgfb2 +/− ; Fbn1 C1039G/+ animals had normal body size and growth with normal blood pressure indices (Supplementary Fig. 4) . These double-heterozygous mice showed a significant increase in aortic root dimension compared to either Fbn1 C1039G/+ or Tgfb2 +/− mice at 2 and 4 months of age (Fig. 5a) . Aortic dilatation was specific to the aortic root, recapitulating the zone of predisposition seen in people with either MFS or LDS. Histological examination showed equivalent elastic fiber fragmentation and greater collagen deposition within the medial compartment of the aortic wall in Tgfb2 +/− and Fbn1 C1039G/+ mice relative to wild-type animals; both phenotypes were greatly accentuated in Tgfb2 +/− ; Fbn1 C1039G/+ mice ( Fig. 5b and  Supplementary Fig. 5 ). IHC showed a graded increase in the nuclear accumulation of phosphorylated Smad2 in the aortic media of all mutant mice compared to wild-type littermates, with a pronounced increase in Tgfb2 +/− ; Fbn1 C1039G/+ aortas (Fig. 5c) . Protein blot analysis, which integrates the performance of all cell types within the aorta, showed a subtle but significant increase in phosphorylated Smad2 levels in Fbn1 C1039G/+ and Tgfb2 +/− ; Fbn1 C1039G/+ mice but no difference in either phosphorylated Smad3 or ERK1/2 at this early time point (4 months) (Supplementary Fig. 5 ). Analysis of mRNA levels in the proximal aorta at 2 months of age showed normal expression of Tgfb2 and Tgfb3 in all three mutant mouse strains; Tgfb2 +/− ; Fbn1 C1039G/+ mice uniquely showed higher expression of Tgfb1 (Fig. 5d) , recapitulating observations in the human aorta (Fig. 3c) . No significant change in Tgfbr1 or Tgfbr2 expression was detected (Supplementary Fig. 6 ). At 4 months of age, both Tgfb2 +/− and Tgfb2 +/− ; Fbn1 C1039G/+ mice had less TGF-β2 in circulation compared to wild-type littermates, whereas the amount of circulating TGF-β2 was higher in Fbn1 C1039G/+ animals ( Supplementary Fig. 7) . Whereas there was a trend of increased circulating TGF-β1 for all three mutant mouse strains, high variability was observed between groups (data not shown).
This study shows that heterozygous mutations in the gene encoding TGF-β2 are sufficient to cause a syndromic presentation of thoracic aortic aneurysm in both people and mice. Given the substantial clinical and mechanistic overlap of this disorder with LDS, categorizing it within the LDS spectrum should facilitate diagnosis and disease management.
The pathogenesis of TGF-β-related vasculopathies seems complex. Whereas the previous finding of mutations affecting TGF-β receptor subunits and intracellular mediators underscored the primary role of this cytokine family in aneurysm initiation and/or progression, the paradoxical association of an unequivocal signature for increased TGF-β signaling in postnatal tissues with mutations that would intuitively impair signaling has engendered controversy regarding the mechanism for LDS spectrum disorders. Attainment of mechanistic insight has been slowed by the myriad interactions and functions supported by TGF-β receptors and intracellular signaling mediators and by the extent of crosstalk with other signaling cascades. The recent demonstration that the cleft palate seen upon neural crest-specific silencing of the Tgfbr2 gene in mice is accompanied by higher p38 signaling, mediated by TGF-β2 and a disease-specific TβR1:TβR3 receptor complex, represents an overt example of this complexity and the potential inadequacy of intuitive disease model predictions 30 .
Although our findings regarding TGFB2 haploinsufficiency and aneurysm represent yet another example of the same paradox, they per GAPDH * * Figure 4 Haploinsufficiency for Tgfb2 causes aortic root aneurysm in mice. (a) Parasternal long-axis echocardiographic systolic images of the aortic root of 8-month-old wild-type (WT; n = 10), Tgfb2 +/− (n = 6) and Fbn1 C1039G/+ mice (n = 9). Arrows denote root dimension. Scale bars, 0.75 mm. (b) Echocardiographic quantification of dimensions at the aortic valve (AoV), aortic root (AoR), sinotubular junction (STJ) and ascending aorta (AscAo) in WT, Tgfb2 +/− and Fbn1 C1039G/+ mice at 8 months of age.
†P < 0.005, ***P < 0.001. There was no significant difference in aortic dimension between Tgfb2 +/− and Fbn1 C1039G/+ mice at this age. (c) Protein blot analysis of mouse ascending aortas showing greater phosphorylation of Smad2 (pSmad2), Smad3 (pSmad3) and Erk (pErk1/2) in 8-month-old Tgfb2 +/− and Fbn1 C1039G/+ mice relative to WT animals. Graphs represent quantification of phosphoprotein blots standardized to Gapdh expression. Error bars, 2 s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001.
npg l e t t e r s may offer experimental opportunities to clarify the mechanism. In the absence of any primary perturbation of intracellular signaling machinery, model systems may be more tractable. One testable hypothesis that derives from our observations is that compensatory upregulation of TGF-β1 expression in the aorta contributes to aortic disease. Future studies will determine whether a targeted reduction in TGF-β1 expression can rescue the TGF-β2 deficiency state and whether the seeming overshoot in compensation reflects the total level of all bioavailable TGF-β ligands or a specific detrimental consequence of upregulation of TGF-β1 in the aorta. Alternatively, low TGF-β signaling in restricted cell populations may be a critical determinant of postnatal disease progression, perhaps setting the stage for paracrine overdrive of adjacent cell types with a relative preservation of signaling potential. It is notable that greater concentrations of TGF-β1 have been documented in the aorta in persons with LDS spectrum phenotypes with loss-of-function SMAD3 mutations 8 and in the circulation of people and mice with MFS 31 . Our observation of a deleterious genetic interaction between an MFS-causing Fbn1 mutation and Tgfb2 haploinsufficiency that causes an LDS spectrum disorder is both novel and informative. MFS is the most comprehensively studied TGF-β-related vasculopathy, with clear evidence in support of increased TGF-β signaling and phenotypic rescue upon administration of TGF-β or ERK antagonists. In this light, pathogenic models that singularly invoke decreased TGF-β signaling for LDS spectrum disorders would be difficult to reconcile with the worsening of disease seen in Tgfb2 +/− ; Fbn1 C1039G/+ animals.
It seems notable that aortic root enlargement can be detected in Fbn1 C1039G/+ and Tgfb2 +/− ; Fbn1 C1039G/+ mice at 2-4 months of age, before overt evidence of excessive Smad2, Smad3 or Erk1/2 activation by protein blot analysis. This may suggest that the average performance of all cells within an aortic segment (the parameter monitored by immunoblots) is less important than the presence of even small subpopulations of misbehaving (high signaling) cells. In keeping with this hypothesis, the specific ERK1/2 inhibitor RDEA-119 completely suppressed abnormal aortic growth in Fbn1 C1039G/+ mice, even when its use was restricted to age groups that did not yet show higher levels of phosphorylated Erk1/2 in the aortic wall by protein blot analyses 12 . Full clarity on these issues will facilitate the development and testing of novel treatment strategies that may have broad applications.
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Methods and any associated references are available in the online version of the paper. l e t t e r s 
